Patients with Epstein–Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease

Slični predmeti

• Myh9 R702C is associated with erythroid abnormality with splenomegaly in mice
  od: Kanematsu, Takeshi, i dr.
  Izdano: (2021)
• Two Cases of the MYH9 Disorder Fechtner Syndrome Diagnosed from Observation of Peripheral Blood Cells before End-Stage Renal Failure
  od: Teshirogi, Shin, i dr.
  Izdano: (2019)
• Expression of the Nonmuscle Myosin Heavy Chain IIA in the Human Kidney and Screening for MYH9 Mutations in Epstein and Fechtner Syndromes
  od: Christelle Arrondel, i dr.
  Izdano: (2002)
• Afadin is localized at cell–cell contact sites in mesangial cells and regulates migratory polarity
  od: Tsurumi, Haruko, i dr.
  Izdano: (2016)
• Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome)
  od: Alessandro Pecci, i dr.
  Izdano: (2008)